Kawata, T., Tada, K., Kobayashi, M., Sakamoto, T., Takiuchi, Y., Iwai, F., . . . Takaori‐Kondo, A. (2017). Dual inhibition of the mTORC1 and mTORC2 signaling pathways is a promising therapeutic target for adult T‐cell leukemia. Cancer Sci.
シカゴスタイル引用形Kawata, Takahito, et al. "Dual Inhibition of the MTORC1 and MTORC2 Signaling Pathways Is a Promising Therapeutic Target for Adult T‐cell Leukemia." Cancer Sci 2017.
MLA引用形式Kawata, Takahito, et al. "Dual Inhibition of the MTORC1 and MTORC2 Signaling Pathways Is a Promising Therapeutic Target for Adult T‐cell Leukemia." Cancer Sci 2017.
警告: この引用は必ずしも正確ではありません.